NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia

Volume: 142, Pages: 237 - 250
Published: Feb 25, 2019
Paper Details
Title
NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia
Published Date
Feb 25, 2019
Volume
142
Pages
237 - 250
© 2025 Pluto Labs All rights reserved.